These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 34716741

  • 1. Assessing the relationship between patient preferences for recontact after BRCA1 or BRCA2 genetic testing and their monitoring coping style in a Norwegian sample.
    Dahle Ommundsen RM, Strømsvik N, Hamang A.
    J Genet Couns; 2022 Apr; 31(2):554-564. PubMed ID: 34716741
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recontact to return new or updated PALB2 genetic results in the clinical laboratory setting.
    Panchal S, Mahajan R, Aujla N, McKay P, Casalino S, Di Gioacchino V, Charames GS, Lefebvre M, Metcalfe KA, Akbari MR, McCuaig JM, Lerner-Ellis J.
    J Med Genet; 2024 Apr 19; 61(5):477-482. PubMed ID: 38124008
    [Abstract] [Full Text] [Related]

  • 5. Practices and Views of US Oncologists and Genetic Counselors Regarding Patient Recontact After Variant Reclassification: Results of a Nationwide Survey.
    Makhnoon S, Davidson E, Shirts B, Arun B, Shete S.
    JCO Precis Oncol; 2023 Jun 19; 7():e2300079. PubMed ID: 37384863
    [Abstract] [Full Text] [Related]

  • 6. Recontacting patients for multigene panel testing in hereditary cancer: Efficacy and insights.
    Sawyer L, Creswick H, Lewandowski R, Quillin J.
    J Genet Couns; 2019 Dec 19; 28(6):1198-1207. PubMed ID: 31553108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of monitoring versus blunting on the public's preferences for information in a hypothetical cancer diagnosis scenario.
    Plamann K, McCarthy Veach P, LeRoy BS, MacFarlane IM, Petzel SV, Zierhut HA.
    J Genet Couns; 2021 Feb 19; 30(1):132-143. PubMed ID: 32583486
    [Abstract] [Full Text] [Related]

  • 10. Recontact: a survey of current practices and BRCA1/2 testing in Japan.
    Sakaguchi T, Tokutomi T, Yoshida A, Yamamoto K, Obata K, Carrieri D, Kelly SE, Fukushima A.
    J Hum Genet; 2023 Aug 19; 68(8):551-557. PubMed ID: 37072622
    [Abstract] [Full Text] [Related]

  • 11. The duty to recontact: attitudes of genetics service providers.
    Fitzpatrick JL, Hahn C, Costa T, Huggins MJ.
    Am J Hum Genet; 1999 Mar 19; 64(3):852-60. PubMed ID: 10053020
    [Abstract] [Full Text] [Related]

  • 12. Recontacting in light of new genetic diagnostic techniques for patients with intellectual disability: Feasibility and parental perspectives.
    Beunders G, Dekker M, Haver O, Meijers-Heijboer HJ, Henneman L.
    Eur J Med Genet; 2018 Apr 19; 61(4):213-218. PubMed ID: 29191497
    [Abstract] [Full Text] [Related]

  • 13. Patient preferences regarding recontact by cancer genetics clinicians.
    Griffin CA, Axilbund JE, Codori AM, Deise G, May B, Pendergrass C, Tillery M, Trimbath JD, Giardiello FM.
    Fam Cancer; 2007 Apr 19; 6(3):265-73. PubMed ID: 17308889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Roles and responsibilities of a medical geneticist.
    Rubinstein WS.
    Fam Cancer; 2008 Apr 19; 7(1):5-14. PubMed ID: 17624600
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Duty to recontact in genomic cancer care: A tool helping to assess the professional's responsibility.
    Ploem MC, Giesbertz NAA, Bredenoord AL, Retèl VP, van Harten WH.
    Eur J Cancer; 2023 Jun 19; 186():22-26. PubMed ID: 37028199
    [Abstract] [Full Text] [Related]

  • 18. A 'joint venture' model of recontacting in clinical genomics: challenges for responsible implementation.
    Dheensa S, Carrieri D, Kelly S, Clarke A, Doheny S, Turnpenny P, Lucassen A.
    Eur J Med Genet; 2017 Jul 19; 60(7):403-409. PubMed ID: 28501562
    [Abstract] [Full Text] [Related]

  • 19. Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.
    Vears DF, Niemiec E, Howard HC, Borry P.
    Eur J Hum Genet; 2018 Dec 19; 26(12):1743-1751. PubMed ID: 30143804
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.